Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications. This compound has shown promising results in clinical studies for metabolic research.
Our tirzepatide UK price is highly competitive for research institutions and pharmaceutical developers. The product is synthesized under strict quality control measures to ensure consistent purity and performance in research settings.
Note: This product is for research use only. Not for human consumption. All orders must be placed by qualified research institutions or pharmaceutical companies.